p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?

  • Authors:
    • Ingrid Norman
    • Sophia Brismar
    • Jie Zhu
    • Vera Gaberi
    • Bjorn Hagmar
    • Anders Hjerpe
    • Sonia Andersson
  • View Affiliations

  • Published online on: December 1, 2007     https://doi.org/10.3892/ijo.31.6.1339
  • Pages: 1339-1343
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A consecutive series of 118 samples from patients referred to colposcopy assessment and follow-up with cytology and biopsies were analysed with immunocytochemical staining to determinate the expression of p16INK4a. Accumulation of p16INK4a antigen has been proposed as a biomarker helpful for the identification of dysplastic cervical cells. In our study all benign cases were negative for p16INK4a, while more than half of the high grade lesions showed moderate or strong reactivity. There was a correlation between CIN grade and p16 INK4a expression levels with more advanced lesions showing stronger reactivity. The correlation between p16INK4a immunoreactivity and the severity of cytological abnormality was stronger, when the diagnosis was based on simultaneous routine cytology (p<0.001, χ2 exact test for trend). There was no or weak reactivity in benign cases, as well as almost all low-grade lesions, while two thirds of high-grade lesions showed moderate or strong staining for p16 INK4a antigen. Thus p16INK4a expression analysis yielded information which is consistent with results from the histopathology and is a simple way of emphasizing the presence of premalignant cell reactive atypias. This staining can be applied to cytological samples, and might be a complement prognostic procedure in order to find women at risk for cervical cancer.

Related Articles

Journal Cover

December 2007
Volume 31 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Norman I, Brismar S, Zhu J, Gaberi V, Hagmar B, Hjerpe A and Andersson S: p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?. Int J Oncol 31: 1339-1343, 2007.
APA
Norman, I., Brismar, S., Zhu, J., Gaberi, V., Hagmar, B., Hjerpe, A., & Andersson, S. (2007). p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?. International Journal of Oncology, 31, 1339-1343. https://doi.org/10.3892/ijo.31.6.1339
MLA
Norman, I., Brismar, S., Zhu, J., Gaberi, V., Hagmar, B., Hjerpe, A., Andersson, S."p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?". International Journal of Oncology 31.6 (2007): 1339-1343.
Chicago
Norman, I., Brismar, S., Zhu, J., Gaberi, V., Hagmar, B., Hjerpe, A., Andersson, S."p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?". International Journal of Oncology 31, no. 6 (2007): 1339-1343. https://doi.org/10.3892/ijo.31.6.1339